Why the study?
Does age at diagnosis affect outcome and treatment in adult patients with Ewing's family of sarcomas?
Does age at diagnosis affect outcome and treatment in adult patients with Ewing's family of sarcomas?
This review examines the controversial role of age at diagnosis in the management and outcomes of adult patients with Ewing's family of sarcomas.
Ewing's sarcoma, peripheral primitive neuroectodermal tumor, and Askin's tumor comprise a single family of tumors, the Ewing's family of tumors, which is characterized by chromosomal translocation. Ewing's sarcoma is known as a malignancy of childhood, but with a median age of 15 years at diagnosis, it should equally be regarded as a malignancy of adolescence and young adulthood. There is much controversy regarding the role of age at diagnosis, with some studies showing older age to be associated with poorer outcome and others showing no association between age and survival. This has led to uncertainty in how best to manage nonpediatric patients with Ewing's sarcoma. This article examines whether age does affect outcome and treatment in this group of tumors.
No takes yet. Share an insight, caveat, or question.
Scurr et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: